Aman M. G. et al. (2005)
Acute and long-term safety and tolerability of risperidone in children with autism.
Journal of Child and Adolescent Psychopharmacology
15(6), pp. 869-884
Aman M. G. et al. (2008)
Cognitive effects of risperidone in children with autism and irritable behavior.
Journal of Child and Adolescent Psychopharmacology
18(3), pp. 227-236
Aman M. G. et al. (2009)
Journal of the American Academy of Child and Adolescent Psychiatry
48(12), pp. 1143-1154
Arnold L. E. et al. (2003)
Journal of the American Academy of Child and Adolescent Psychiatry
42(12), pp. 1443-1450
Cicchetti D. V. et al. (2008)
Reliability of the ADI-R: Multiple examiners evaluate a single case
Journal of Autism and Developmental Disorders
April, 38(4), pp. 764-770
Journal of Autism and Developmental Disorders
39(8), pp. 1163-1172
Journal of Autism and Developmental Disorders
40(10), pp. 1209-1218.
Journal of Autism and Developmental Disorders
33(1), pp. 77-85
Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
9(2), pp. 99-107
Scahill L. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(2), pp. 136-146
Scahill L. et al. (2001)
Journal of Child and Adolescent Psychopharmacology
Winter, 11(4), pp, 377-88.
Scahill L. , Koenig K. (1999)
Pharmacotherapy in children and adolescents with pervasive developmental disorders.
Journal of Child and Adolescent Psychiatric Nursing
12(1), pp. 41-43
Vitiello B. et al. (2005)
Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
Journal of Clinical Psychopharmacology
25(6), pp. 565-569
Volkmar F. R. , Koenig K. , State M. (2005)
London: John Wiley and Sons Inc
White S. W. , Koenig K. , Scahill L. (2010)
Group social skills instruction for adolescents with high-functioning autism spectrum disorders.
Focus on Autism and Other Developmental Disabilities
25(4), pp. 209-219
Showing 1 to 18 of 18 Results